STOCK TITAN

Helen of Troy Limited Reports Third Quarter Fiscal 2021 Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Helen of Troy Limited (NASDAQ: HELE), designer, developer and worldwide marketer of consumer brand-name housewares, health and home and beauty products, today reported results for the three-month period ended November 30, 2020.

Executive Summary – Third Quarter of Fiscal 2021

  • Consolidated net sales revenue increase of 34.3%, including:
    • An increase in Leadership Brand net sales of 33.9%
    • An increase in online channel net sales of approximately 34%
    • Organic business net sales growth of 30.3%
    • Core business net sales growth of 35.2%
  • GAAP consolidated operating income of $100.7 million, or 15.8% of net sales, compared to $79.3 million, or 16.7% of net sales, for the same period last year
  • Non-GAAP consolidated adjusted operating income increase of 24.0% to $111.9 million, or 17.6% of net sales, compared to $90.3 million, or 19.0% of net sales, for the same period last year
  • GAAP diluted EPS of $3.34, compared to $2.71 for the same period last year
  • Non-GAAP adjusted diluted EPS increase of 20.5% to $3.76, compared to $3.12 for the same period last year
  • Net cash provided by operating activities for the first nine months of the fiscal year of $249.7 million, compared to $101.4 million for the same period last year
  • Non-GAAP free cash flow for the first nine months of the fiscal year of $230.3 million, compared to $88.2 million for the same period last year
  • Repurchased 960,829 shares of common stock in the open market during the quarter for $191.6 million, at an average price of $199.42 per share

Julien R. Mininberg, Chief Executive Officer, stated: “Our business delivered an exceptional third quarter in what is shaping up to be another year of outstanding results for Helen of Troy. We delivered 34.3% growth in consolidated net sales behind continued momentum across each of our business segments, our Leadership Brands, the online channel, brick and mortar, organic business, core business, and international. During the quarter, adjusted EPS grew 20.5%, even as we invested in key initiatives designed to continue driving our value creation flywheel for next fiscal year and for the back half of Phase II. Year to date, we have outstanding momentum, with consolidated net sales growth of 25.6%, adjusted EPS growth of 35.4%, and growth in cash flow from operations of 146.3% to $249.7 million. We are very pleased to deliver these results and now provide full fiscal year guidance projecting that Helen of Troy will cross the $2 billion sales milestone for the first time and grow its adjusted EPS by $2.20 per share or more this year. This is tremendous progress in our second year of Phase II, and well ahead of the five-year glidepath we laid out during our May 2019 Investor Day. The strength of our execution is a testament to our exceptional associates around the world who continue to thrive as we rise together to overcome the many challenges of COVID-19, live our culture, and build for the future.”

Mr. Mininberg concluded: “We are excited to be in a position this fiscal year to use the strength of our results and balance sheet to make long-term investments needed to catch up with our rapid growth over the past several years and to invest in the building blocks and capabilities we believe will create incremental revenue and earnings growth during the rest of Phase II. We like our chosen initiatives, remain clearly focused on leveraging our diversified portfolio and expect to continue to develop additional opportunities to further supplement future earnings growth as we head into fiscal 2022.”

 

Three Months Ended November 30,

(in thousands)

Housewares

 

Health & Home

 

Beauty

 

Total

Fiscal 2020 sales revenue, net

$

183,211

 

 

$

185,810

 

 

$

105,716

 

 

$

474,737

 

Organic business (1)

38,836

 

 

62,887

 

 

42,072

 

 

143,795

 

Impact of foreign currency

353

 

 

1,461

 

 

(110

)

 

1,704

 

Acquisition (2)

 

 

 

 

17,501

 

 

17,501

 

Change in sales revenue, net

39,189

 

 

64,348

 

 

59,463

 

 

163,000

 

Fiscal 2021 sales revenue, net

$

222,400

 

 

$

250,158

 

 

$

165,179

 

 

$

637,737

 

 

 

 

 

 

 

 

 

Total net sales revenue growth (decline)

21.4

%

 

34.6

%

 

56.2

%

 

34.3

%

Organic business

21.2

%

 

33.8

%

 

39.8

%

 

30.3

%

Impact of foreign currency

0.2

%

 

0.8

%

 

(0.1

)%

 

0.4

%

Acquisition

%

 

%

 

16.6

%

 

3.7

%

 

 

 

 

 

 

 

 

Operating margin (GAAP)

 

 

 

 

 

 

 

Fiscal 2021

16.9

%

 

12.2

%

 

19.7

%

 

15.8

%

Fiscal 2020

23.1

%

 

13.1

%

 

11.9

%

 

16.7

%

Adjusted operating margin (non-GAAP)

 

 

 

 

 

 

 

Fiscal 2021

18.4

%

 

14.1

%

 

21.7

%

 

17.6

%

Fiscal 2020

24.3

%

 

15.5

%

 

16.0

%

 

19.0

%

Consistent with its strategy of focusing on its Leadership Brands, during the fourth quarter of fiscal 2020, the Company committed to a plan to divest certain assets within its mass channel personal care business (“Personal Care”). The assets to be divested include intangible assets, inventory and fixed assets related to the Company's mass channel liquids, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium. The Company expects the divestiture to occur within fiscal 2021. Accordingly, the Company has classified the identified assets of the disposal group as held for sale. In connection with this change, the Company now defines Core as strategic business that it expects to be an ongoing part of its operations, and Non-Core as business or assets (including assets held for sale) that it expects to divest within a year of its designation as Non-Core. Organic business now refers to net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand is acquired, not including the impact that foreign currency had on reported net sales revenue.

 

Three Months Ended November 30,

(in thousands)

Housewares

 

Health & Home

 

Beauty

 

Total

Fiscal 2020 sales revenue, net

$

183,211

 

 

$

185,810

 

 

$

105,716

 

 

$

474,737

 

Core business (2) (3)

39,189

 

 

64,348

 

 

63,487

 

 

167,024

 

Non-Core business (Personal Care) (3)

 

 

 

 

(4,024

)

 

(4,024

)

Change in sales revenue, net

39,189

 

 

64,348

 

 

59,463

 

 

163,000

 

Fiscal 2021 sales revenue, net

$

222,400

 

 

$

250,158

 

 

$

165,179

 

 

$

637,737

 

 

 

 

 

 

 

 

 

Total net sales revenue growth (decline)

21.4

%

 

34.6

%

 

56.2

%

 

34.3

%

Core business

21.4

%

 

34.6

%

 

60.1

%

 

35.2

%

Non-Core business (Personal Care)

%

 

%

 

(3.8

)%

 

(0.8

)%

Consolidated Operating Results - Third Quarter Fiscal 2021 Compared to Third Quarter Fiscal 2020

  • Consolidated net sales revenue increased $163.0 million, or 34.3%, to $637.7 million compared to $474.7 million. The growth was driven by an Organic business increase of $143.8 million, or 30.3%, primarily reflecting growth in consolidated brick and mortar, online, and international sales. The Drybar Products acquisition also contributed $17.5 million, or 3.7% to consolidated net sales revenue growth. These factors were partially offset by reduced store traffic at certain retail brick and mortar stores, a soft back-to-school season due to COVID-19 related school closures and a decline in Non-Core business.
  • Consolidated gross profit margin increased 0.9 percentage points to 45.1%, compared to 44.2%. The increase was primarily due to a favorable product mix within Health & Home and the Organic Beauty business, the favorable impact of the Drybar Products acquisition, and a favorable channel mix within the Housewares segment. These factors were partially offset by higher inbound freight expense and an unfavorable product mix in the Housewares segment.
  • Consolidated selling, general and administrative expense (“SG&A”) ratio increased 1.8 percentage points to 29.3%, compared to 27.5%. The increase was primarily due to increased marketing expense, increased freight and distribution expense, higher royalty expense, increased legal and other professional fees, and higher bad debt expense. These factors were partially offset by the impact that higher net sales revenue had on net operating leverage, travel expense reductions due to COVID-19, and the favorable comparative impact of acquisition-related expenses for the purchase of Drybar Products incurred in the prior year period.
  • Consolidated operating income was $100.7 million, or 15.8% of net sales revenue, compared to $79.3 million, or 16.7% of net sales revenue. The decrease in consolidated operating margin was primarily driven by the increase in the SG&A ratio, partially offset by the increase in gross profit margin.
  • Income tax expense as a percentage of income before tax was 14.0% compared to 10.3% for the same period last year. The year-over-year increase in the effective tax rate is primarily due to an increase in liabilities related to uncertain tax positions.
  • Net income increased 22.6% to $84.2 million, compared to $68.7 million. Diluted EPS was $3.34 compared to $2.71. Diluted EPS increased primarily due to higher operating income in the Beauty and Health & Home segments, partially offset by lower operating income in the Housewares segment and higher income tax expense.
  • Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) increased 24.0% to $117.0 million compared to $94.4 million.

On an adjusted basis for the third quarter of fiscal 2021 and 2020, excluding non-cash asset impairment charges, acquisition-related expenses, restructuring charges, tax reform, amortization of intangible assets, and non-cash share-based compensation, as applicable:

  • Adjusted operating income increased $21.6 million, or 24.0%, to $111.9 million, or 17.6% of net sales, compared to $90.3 million, or 19.0% of net sales. The 1.4 percentage point decrease in adjusted operating margin primarily reflects increased marketing expense, increased freight and distribution expense, an unfavorable product mix in the Housewares segment, higher royalty expense, increased legal and other professional fees, and higher bad debt expense. These factors were partially offset by the favorable impact that higher overall net sales revenue had on operating leverage, a favorable product mix within Health & Home and the Organic Beauty business, a favorable channel mix within the Housewares segment, and travel expense reductions due to COVID-19.
  • Adjusted income increased $15.7 million, or 19.8%, to $94.8 million, compared to $79.1 million for the same period last year. Adjusted diluted EPS increased 20.5% to $3.76 compared to $3.12. The increase in adjusted diluted EPS was primarily due to higher operating income in the Beauty and Health & Home segments, partially offset by lower operating income in the Housewares segment and higher income tax expense.

Segment Operating Results - Third Quarter Fiscal 2021 Compared to Third Quarter Fiscal 2020

Housewares net sales revenue increased $39.2 million, or 21.4%, to $222.4 million, compared to $183.2 million. Growth was driven by an Organic business increase of $38.8 million, or 21.2%, primarily due to higher demand for OXO brand products as consumers spent more time at home cooking, cleaning, organizing and pantry loading in response to COVID-19, which resulted in increases in brick and mortar, online and international sales. These factors were partially offset by the COVID-19 related impact of reduced store traffic at certain retail brick and mortar stores, a soft back-to-school season due to COVID-19, lower closeout channel sales and increased competitive activity. Operating income was $37.7 million, or 16.9% of segment net sales revenue, compared to $42.3 million, or 23.1% of segment net sales revenue. The 6.2 percentage point decrease in segment operating margin was primarily due to a less favorable product mix, higher marketing expense, increased freight and distribution expense to support strong demand, higher royalty expense, and increased legal and other professional fees. These factors were partially offset by the favorable impact that higher overall net sales revenue had on operating leverage, a more favorable channel mix, and travel expense reductions due to COVID-19. Adjusted operating income decreased 8.3% to $40.9 million, or 18.4% of segment net sales revenue compared to $44.6 million, or 24.3% of segment net sales revenue.

Health & Home net sales revenue increased $64.3 million, or 34.6%, to $250.2 million, compared to $185.8 million. The increase was primarily driven by an Organic business increase of $62.9 million, or 33.8%, primarily due to strong consumer demand for healthcare and healthy living products in domestic and international markets, primarily in thermometry and air purification, in both brick and mortar and online channels, mainly attributable to COVID-19. These factors were partially offset by declines in non-strategic categories. Operating income was $30.5 million, or 12.2% of segment net sales revenue, compared to $24.4 million, or 13.1% of segment net sales revenue. The 0.9 percentage point decrease in segment operating margin was primarily due to increased marketing expense, higher performance-based annual incentive compensation expense, higher royalty expense, and the unfavorable impact of foreign currency exchange and forward contract settlements year-over-year. These factors were partially offset by the favorable impact that higher overall net sales revenue had on operating leverage and the impact of a more favorable product mix. Adjusted operating income increased 22.5% to $35.3 million, or 14.1% of segment net sales revenue, compared to $28.8 million, or 15.5% of segment net sales revenue.

Beauty net sales revenue increased $59.5 million, or 56.2%, to $165.2 million, compared to $105.7 million. The increase was driven by an Organic business increase of $42.1 million, or 39.8%, as well as the net sales revenue contribution of $17.5 million, or 16.6% growth, from the acquisition of Drybar Products. The Organic business increase primarily reflects growth in the appliance category in both online and brick and mortar channels driven by the strength of the One-Step family of products, a shift to greater and more aggressive early season retail holiday promotions during the third quarter, expanded distribution, primarily in the club channel, and an increase in international sales. These factors were partially offset by reduced store traffic at certain retail brick and mortar stores due to COVID-19 and a net sales revenue decline in Non-Core business. Operating income was $32.6 million, or 19.7% of segment net sales revenue, compared to $12.6 million, or 11.9% of segment net sales revenue. The 7.8 percentage point increase in segment operating margin was primarily due to the favorable impact that higher overall net sales revenue had on operating leverage, the margin impact of a more favorable product mix, the favorable comparative impact of acquisition-related expenses for the purchase of Drybar Products incurred in the prior year period, and travel expense reductions due to COVID-19. These factors were partially offset by higher personnel expense related to the acquisition of Drybar Products, increased marketing expense, higher performance-based annual incentive compensation expense, higher bad debt expense, and higher legal and other professional fees. Adjusted operating income increased 111.7% to $35.8 million, or 21.7% of segment net sales revenue, compared to $16.9 million, or 16.0% of segment net sales revenue.

Balance Sheet and Cash Flow Highlights - Third Quarter Fiscal 2021 Compared to Third Quarter Fiscal 2020

  • Cash and cash equivalents totaled $156.7 million, compared to $19.6 million.
  • Accounts receivable turnover was 70.0 days, compared to 68.9 days.
  • Inventory was $383.4 million, compared to $333.7 million. Trailing twelve-month inventory turnover was 3.6 times compared to 2.9 times.
  • Total short- and long-term debt was $440.4 million, compared to $244.2 million.
  • Net cash provided by operating activities for the first nine months of the fiscal year was $249.7 million, compared to $101.4 million.

Subsequent Event

On December 22, 2020, the Company entered into an amended and extended Trademark License Agreement with Revlon to license Revlon’s trademark for hair care appliances and tools (the “Revlon License”). The Revlon License grants the Company an exclusive, global, fully paid-up license to use the licensed trademark to manufacture, sell and distribute licensed merchandise in accordance with the terms of the agreement. The Revlon License has an initial term of 40 years, which will automatically renew at the end of the initial term for three consecutive additional 20-year periods unless the Company gives notice of non-renewal. The Revlon License amends and restates the existing Revlon trademark licensing agreements entirely, and eliminates ongoing royalties the Company has historically paid and recognized as expense within SG&A in accordance with such agreements. In exchange for this exclusive global license, the Company paid a one-time, up-front license fee of $72.5 million, which will be recorded as an intangible asset at cost and amortized on a straight-line basis over a useful life of 40 years, representing the initial term. As a result of the Revlon License, the Company is no longer obligated to pay royalties or any other fees to Revlon, and thus will not recognize these expenses after December 22, 2020, the effective date of the Revlon License.

Fiscal 2021 Annual Outlook

For fiscal 2021, the Company expects consolidated net sales revenue in the range of $2.075 to $2.1 billion, which implies consolidated sales growth of 21.5% to 23.0%.

The Company’s net sales outlook reflects the following expectations by segment:

  • Housewares net sales growth of 12.0% to 12.5%;
  • Health & Home net sales growth of 27.5% to 30.0%; and
  • Beauty net sales growth of 27.0% to 28.0%.

The Company expects consolidated GAAP diluted EPS of $10.29 to $10.46 and non-GAAP adjusted diluted EPS in the range of $11.50 to $11.70, which excludes any asset impairment charges, restructuring charges, tax reform, share-based compensation expense and intangible asset amortization expense.

The Company’s net sales and EPS growth outlook reflects the following:

  • the assumption that COVID-19 related demand trends seen in the second and third quarters of fiscal 2021 continue through the fourth quarter;
  • the assumption that the impact of the cough/cold/flu season on the fourth quarter will be below average due to the COVID-19 impact on back to school, work from home, travel, brick and mortar shopping, and group gatherings, compared to an above average impact in the same period last year;
  • the more difficult comparison to the fourth quarter of fiscal 2020, which included initial COVID-19 demand surges in the Health & Home segment and an initial surge in demand for the One-Step family of products in the Beauty segment;
  • an estimated increase in short- and long-term growth investments of approximately 50% for the full fiscal year 2021, which falls entirely in the second half of the year due to cost reduction initiatives in place during the first half of the year;
  • the assumption that December 2020 foreign currency exchange rates will remain constant for the remainder of the fiscal year; and
  • an estimated weighted average diluted shares outstanding of 25.3 million.

The Company expects a reported GAAP effective tax rate range of 6.7% to 6.8%, and an adjusted effective tax rate range of 9.5% to 9.7% for the full fiscal year 2021. Please refer to the schedule entitled “Effective Tax Rate (GAAP) and Adjusted Effective Tax Rate (Non-GAAP)” in the accompanying tables to this press release.

The Company expects capital asset expenditures of $32 to $35 million for the full fiscal year 2021, which includes expected initial expenditures related to a new 2 million square foot distribution facility with state of the art automation for our Housewares segment. The Company expects intangible asset expenditures of $74 to $75 million, which includes the $72.5 million incurred in December related to the Revlon License agreement.

The likelihood and potential impact of any fiscal 2021 acquisitions and divestitures, future asset impairment charges, future foreign currency fluctuations, or further share repurchases are unknown and cannot be reasonably estimated; therefore, they are not included in the Company’s sales and earnings outlook.

Conference Call and Webcast

The Company will conduct a teleconference in conjunction with today’s earnings release. The teleconference begins at 9:00 a.m. Eastern Time today, Thursday, January 7, 2021. Investors and analysts interested in participating in the call are invited to dial (877) 407-3982 approximately ten minutes prior to the start of the call. The conference call will also be webcast live at: http://investor.helenoftroy.com. A telephone replay of this call will be available at 12:00 p.m. Eastern Time on January 7, 2021 until 11:59 p.m. Eastern Time on January 14, 2021 and can be accessed by dialing (844) 512-2921 and entering replay pin number 13714008. A replay of the webcast will remain available on the website for one year.

Non-GAAP Financial Measures

The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States of America (“GAAP”). To supplement its presentation, the Company discloses certain financial measures that may be considered non-GAAP such as adjusted operating income, adjusted operating margin, adjusted effective tax rate, adjusted income, adjusted diluted earnings per share (“EPS”), Core and Non-Core adjusted diluted EPS, EBITDA, adjusted EBITDA, and free cash flow, which are presented in accompanying tables to this press release along with a reconciliation of these financial measures to their corresponding GAAP-based measures presented in the Company’s condensed consolidated statements of income and cash flows. For additional information see Note 9 to the accompanying tables to this Press Release.

About Helen of Troy Limited

Helen of Troy Limited (NASDAQ: HELE) is a leading global consumer products company offering creative solutions for its customers through a strong portfolio of well-recognized and widely-trusted brands, including OXO, Hydro Flask, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar. We sometimes refer to these brands as our Leadership Brands. All trademarks herein belong to Helen of Troy Limited (or its subsidiaries) and/or are used under license from their respective licensors.

For more information about Helen of Troy, please visit http://investor.helenoftroy.com

Forward Looking Statements

Certain written and oral statements made by the Company and subsidiaries of the Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this press release. Generally, the words “anticipates”, “believes”, “expects”, “plans”, “may”, “will”, “should”, “seeks”, “estimates”, “project”, “predict”, “potential”, “continue”, “intends”, and other similar words identify forward-looking statements. All statements that address operating results, events or developments that the Company expects or anticipates will occur in the future, including statements related to sales, earnings per share results, and statements expressing general expectations about future operating results, are forward-looking statements and are based upon its current expectations and various assumptions. The Company believes there is a reasonable basis for these expectations and assumptions, but there can be no assurance that the Company will realize these expectations or that these assumptions will prove correct. Forward-looking statements are subject to risks that could cause them to differ materially from actual results. Accordingly, the Company cautions readers not to place undue reliance on forward-looking statements. The forward-looking statements contained in this press release should be read in conjunction with, and are subject to and qualified by, the risks described in the Company’s Form 10-K for the year ended February 29, 2020, and in the Company's other filings with the SEC. Investors are urged to refer to the risk factors referred to above for a description of these risks. Such risks include, among others, our ability to successfully manage the demand, supply and operational challenges associated with the actual or perceived effects of COVID-19 and any similar future public health crisis, pandemic or epidemic, our ability to deliver products to our customers in a timely manner and according to their fulfillment standards, the costs of complying with the business demands and requirements of large sophisticated customers, our dependence on the strength of retail economies and vulnerabilities to any prolonged economic downturn, including from the effects of COVID-19, our relationships with key customers and licensors, our dependence on sales to several large customers and the risks associated with any loss or substantial decline in sales to top customers, expectations regarding recent, pending and future acquisitions or divestitures, including our ability to realize anticipated cost savings, synergies and other benefits along with our ability to effectively integrate acquired businesses or separate divested businesses, circumstances which may contribute to future impairment of goodwill, intangible or other long-lived assets, the retention and recruitment of key personnel, the costs, complexity and challenges of upgrading and managing our global information systems, the risks associated with cybersecurity and information security breaches, the risks associated with global legal developments regarding privacy and data security could result in changes to our business practices, penalties, increased cost of operations, or otherwise harm our business, risks associated with foreign currency exchange rate fluctuations, the risks associated with accounting for tax positions, tax audits and related disputes with taxing authorities, the risks of potential changes in laws in the U.S. or abroad, including tax laws, regulations or treaties, employment and health insurance laws and regulations, laws relating to environmental policy, personal data, financial regulation, transportation policy and infrastructure policy along with the costs and complexities of compliance with such laws, our ability to continue to avoid classification as a controlled foreign corporation, the risks of new legislation enacted in Bermuda and Barbados in response to the European Union’s review of harmful tax competition, risks associated with weather conditions, the duration and severity of the cold and flu season and other related factors, our dependence on foreign sources of supply and foreign manufacturing, and associated operational risks including, but not limited to, long lead times, consistent local labor availability and capacity, and timely availability of sufficient shipping carrier capacity, the impact of changing costs of raw materials, labor and energy on cost of goods sold and certain operating expenses, the risks associated with significant tariffs or other restrictions on imports from China or any retaliatory trade measures taken by China, the risks associated with the geographic concentration and peak season capacity of certain U.S. distribution facilities, our projections of product demand, sales and net income are highly subjective in nature and future sales and net income could vary in a material amount from such projections, the risks associated with the use of trademarks licensed from and to third parties, our ability to develop and introduce a continuing stream of new products to meet changing consumer preferences, trade barriers, exchange controls, expropriations, and other risks associated with U.S. and foreign operations, the risks to our liquidity as a result of changes to capital market conditions and other constraints or events that impose constraints on our cash resources and ability to operate our business, the risks associated with product recalls, product liability, other claims, and related litigation against us and the risks associated with changes in regulations or product certifications.

 

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(Unaudited) (in thousands, except per share data)

 

 

Three Months Ended November 30,

 

2020

 

2019

Sales revenue, net

$

637,737

 

 

100.0

%

 

$

474,737

 

 

100.0

%

Cost of goods sold

350,410

 

 

54.9

%

 

264,764

 

 

55.8

%

Gross profit

287,327

 

 

45.1

%

 

209,973

 

 

44.2

%

Selling, general and administrative expense (“SG&A”)

186,630

 

 

29.3

%

 

130,692

 

 

27.5

%

Restructuring charges

(12

)

 

%

 

12

 

 

%

Operating income

100,709

 

 

15.8

%

 

79,269

 

 

16.7

%

Non-operating income, net

93

 

 

%

 

92

 

 

%

Interest expense

(2,926

)

 

(0.5

)%

 

(2,767

)

 

(0.6

)%

Income before income tax

97,876

 

 

15.3

%

 

76,594

 

 

16.1

%

Income tax expense

13,721

 

 

2.2

%

 

7,895

 

 

1.7

%

Net income

$

84,155

 

 

13.2

%

 

$

68,699

 

 

14.5

%

 

 

 

 

 

 

 

 

Diluted earnings per share (“EPS”)

$

3.34

 

 

 

 

$

2.71

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock used in computing diluted EPS

25,192

 

 

 

 

25,396

 

 

 

 
 

 

Nine Months Ended November 30,

 

2020

 

2019

Sales revenue, net

$

1,589,424

 

 

100.0

%

 

$

1,265,067

 

 

100.0

%

Cost of goods sold

892,460

 

 

56.1

%

 

723,216

 

 

57.2

%

Gross profit

696,964

 

 

43.9

%

 

541,851

 

 

42.8

%

SG&A

439,646

 

 

27.7

%

 

359,794

 

 

28.4

%

Restructuring charges

355

 

 

%

 

1,061

 

 

0.1

%

Operating income

256,963

 

 

16.2

%

 

180,996

 

 

14.3

%

Non-operating income, net

440

 

 

%

 

313

 

 

%

Interest expense

(9,568

)

 

(0.6

)%

 

(9,291

)

 

(0.7

)%

Income before income tax

247,835

 

 

15.6

%

 

172,018

 

 

13.6

%

Income tax expense

16,061

 

 

1.0

%

 

16,530

 

 

1.3

%

Net income

$

231,774

 

 

14.6

%

 

$

155,488

 

 

12.3

%

 

 

 

 

 

 

 

 

Diluted EPS

$

9.14

 

 

 

 

$

6.15

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock used in computing diluted EPS

25,350

 

 

 

 

25,295

 

 

 

Condensed Consolidated Statements of Income and Reconciliation of Non-GAAP Financial Measures – Adjusted Operating Income, Adjusted Income and Adjusted Diluted EPS (2) (9)

(Unaudited) (in thousands, except per share data)

 

 

Three Months Ended November 30, 2020

 

As Reported
(GAAP)

 

Adjustments

 

Adjusted
(Non-GAAP)

Sales revenue, net

$

637,737

 

 

100.0

%

 

$

 

 

$

637,737

 

 

100.0

%

Cost of goods sold

350,410

 

 

54.9

%

 

 

 

350,410

 

 

54.9

%

Gross profit

287,327

 

 

45.1

%

 

 

 

287,327

 

 

45.1

%

SG&A

186,630

 

 

29.3

%

 

(4,501

)

(4)

175,390

 

 

27.5

%

 

 

 

 

 

(6,739

)

(5)

 

 

 

Restructuring charges

(12

)

 

%

 

12

 

(6)

 

 

%

Operating income

100,709

 

 

15.8

%

 

11,228

 

 

111,937

 

 

17.6

%

Non-operating income, net

93

 

 

%

 

 

 

93

 

 

%

Interest expense

(2,926

)

 

(0.5

)%

 

 

 

(2,926

)

 

(0.5

)%

Income before income tax

97,876

 

 

15.3

%

 

11,228

 

 

109,104

 

 

17.1

%

Income tax expense

13,721

 

 

2.2

%

 

607

 

 

14,328

 

 

2.2

%

Net income

$

84,155

 

 

13.2

%

 

$

10,621

 

 

$

94,776

 

 

14.9

%

 

 

 

 

 

 

 

 

 

 

Diluted EPS

$

3.34

 

 

 

 

$

0.42

 

 

$

3.76

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock used in computing diluted EPS

25,192

 

 

 

 

 

 

25,192

 

 

 

 

 

Three Months Ended November 30, 2019

 

As Reported
(GAAP)

 

Adjustments

 

Adjusted
(Non-GAAP)

Sales revenue, net

$

474,737

 

 

100.0

%

 

$

 

 

$

474,737

 

 

100.0

%

Cost of goods sold

264,764

 

 

55.8

%

 

 

 

264,764

 

 

55.8

%

Gross profit

209,973

 

 

44.2

%

 

 

 

209,973

 

 

44.2

%

SG&A

130,692

 

 

27.5

%

 

(4,790

)

(4)

119,669

 

 

25.2

%

 

 

 

 

 

(4,758

)

(5)

 

 

 

 

 

 

 

 

(1,475

)

(7)

 

 

 

Restructuring charges

12

 

 

%

 

(12

)

(6)

 

 

%

Operating income

79,269

 

 

16.7

%

 

11,035

 

 

90,304

 

 

19.0

%

Non-operating income, net

92

 

 

%

 

 

 

92

 

 

%

Interest expense

(2,767

)

 

(0.6

)%

 

 

 

(2,767

)

 

(0.6

)%

Income before income tax

76,594

 

 

16.1

%

 

11,035

 

 

87,629

 

 

18.5

%

Income tax expense

7,895

 

 

1.7

%

 

617

 

 

8,512

 

 

1.8

%

Net income

$

68,699

 

 

14.5

%

 

$

10,418

 

 

$

79,117

 

 

16.7

%

 

 

 

 

 

 

 

 

 

 

Diluted EPS

$

2.71

 

 

 

 

$

0.41

 

 

$

3.12

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock used in computing diluted EPS

25,396

 

 

 

 

 

 

25,396

 

 

 

Condensed Consolidated Statements of Income and Reconciliation of Non-GAAP Financial Measures – Adjusted Operating Income, Adjusted Income and Adjusted Diluted EPS (2) (9)

(Unaudited) (in thousands, except per share data)

 

 

Nine Months Ended November 30, 2020

 

As Reported
(GAAP)

 

Adjustments

 

Adjusted
(Non-GAAP)

Sales revenue, net

$

1,589,424

 

 

100.0

%

 

$

 

 

$

1,589,424

 

 

100.0

%

Cost of goods sold

892,460

 

 

56.1

%

 

 

 

892,460

 

 

56.1

%

Gross profit

696,964

 

 

43.9

%

 

 

 

696,964

 

 

43.9

%

SG&A

439,646

 

 

27.7

%

 

(13,527

)

(4)

405,465

 

 

25.5

%

 

 

 

 

 

(20,654

)

(5)

 

 

 

Restructuring charges

355

 

 

%

 

(355

)

(6)

 

 

%

Operating income

256,963

 

 

16.2

%

 

34,536

 

 

291,499

 

 

18.3

%

Non-operating income, net

440

 

 

%

 

 

 

440

 

 

%

Interest expense

(9,568

)

 

(0.6

)%

 

 

 

(9,568

)

 

(0.6

)%

Income before income tax

247,835

 

 

15.6

%

 

34,536

 

 

282,371

 

 

17.8

%

Income tax expense

16,061

 

 

1.0

%

 

11,416

 

 

27,477

 

 

1.7

%

Net income

$

231,774

 

 

14.6

%

 

$

23,120

 

 

$

254,894

 

 

16.0

%

 

 

 

 

 

 

 

 

 

 

Diluted EPS

$

9.14

 

 

 

 

$

0.91

 

 

$

10.05

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock used in computing diluted EPS

25,350

 

 

 

 

 

 

25,350

 

 

 

 

 

Nine Months Ended November 30, 2019

 

As Reported
(GAAP)

 

Adjustments

 

Adjusted
(Non-GAAP)

Sales revenue, net

$

1,265,067

 

 

100.0

%

 

$

 

 

$

1,265,067

 

 

100.0

%

Cost of goods sold

723,216

 

 

57.2

%

 

 

 

723,216

 

 

57.2

%

Gross profit

541,851

 

 

42.8

%

 

 

 

541,851

 

 

42.8

%

SG&A

359,794

 

 

28.4

%

 

(13,129

)

(4)

326,447

 

 

25.8

%

 

 

 

 

 

(18,743

)

(5)

 

 

 

 

 

 

 

 

(1,475

)

(7)

 

 

 

Restructuring charges

1,061

 

 

0.1

%

 

(1,061

)

(6)

 

 

%

Operating income

180,996

 

 

14.3

%

 

34,408

 

 

215,404

 

 

17.0

%

Non-operating income, net

313

 

 

%

 

 

 

313

 

 

%

Interest expense

(9,291

)

 

(0.7

)%

 

 

 

(9,291

)

 

(0.7

)%

Income before income tax

172,018

 

 

13.6

%

 

34,408

 

 

206,426

 

 

16.3

%

Income tax expense

16,530

 

 

1.3

%

 

2,145

 

 

18,675

 

 

1.5

%

Net income

$

155,488

 

 

12.3

%

 

$

32,263

 

 

$

187,751

 

 

14.8

%

 

 

 

 

 

 

 

 

 

 

Diluted EPS

$

6.15

 

 

 

 

$

1.28

 

 

$

7.42

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock used in computing diluted EPS

25,295

 

 

 

 

 

 

25,295

 

 

 

Consolidated and Segment Net Sales Revenue

(Unaudited) (in thousands)

 

 

Three Months Ended November 30,

 

Housewares

 

Health & Home

 

Beauty

 

Total

Fiscal 2020 sales revenue, net

$

183,211

 

 

$

185,810

 

 

$

105,716

 

 

$

474,737

 

Organic business (1)

38,836

 

 

62,887

 

 

42,072

 

 

143,795

 

Impact of foreign currency

353

 

 

1,461

 

 

(110

)

 

1,704

 

Acquisition (2)

 

 

 

 

17,501

 

 

17,501

 

Change in sales revenue, net

39,189

 

 

64,348

 

 

59,463

 

 

163,000

 

Fiscal 2021 sales revenue, net

$

222,400

 

 

$

250,158

 

 

$

165,179

 

 

$

637,737

 

 

 

 

 

 

 

 

 

Total net sales revenue growth (decline)

21.4

%

 

34.6

%

 

56.2

%

 

34.3

%

Organic business

21.2

%

 

33.8

%

 

39.8

%

 

30.3

%

Impact of foreign currency

0.2

%

 

0.8

%

 

(0.1

)%

 

0.4

%

Acquisition

%

 

%

 

16.6

%

 

3.7

%

 
 

 

Nine Months Ended November 30,

 

Housewares

 

Health & Home

 

Beauty

 

Total

Fiscal 2020 sales revenue, net

$

496,017

 

 

$

499,543

 

 

$

269,507

 

 

$

1,265,067

 

Organic business (1)

68,803

 

 

162,138

 

 

60,946

 

 

291,887

 

Impact of foreign currency

71

 

 

(113

)

 

(3,121

)

 

(3,163

)

Acquisition (2)

 

 

 

 

35,633

 

 

35,633

 

Change in sales revenue, net

68,874

 

 

162,025

 

 

93,458

 

 

324,357

 

Fiscal 2021 sales revenue, net

$

564,891

 

 

$

661,568

 

 

$

362,965

 

 

$

1,589,424

 

 

 

 

 

 

 

 

 

Total net sales revenue growth (decline)

13.9

%

 

32.4

%

 

34.7

%

 

25.6

%

Organic business

13.9

%

 

32.5

%

 

22.6

%

 

23.1

%

Impact of foreign currency

%

 

%

 

(1.2

)%

 

(0.3

)%

Acquisition

%

 

%

 

13.2

%

 

2.8

%

Leadership Brand and Other Net Sales Revenue (2)

(Unaudited) (in thousands)

 

 

Three Months Ended November 30,

 

2020

 

2019

 

$ Change

 

% Change

Leadership Brand sales revenue, net (8)

$

508,210

 

 

$

379,604

 

 

$

128,606

 

 

33.9

%

All other sales revenue, net

129,527

 

 

95,133

 

 

34,394

 

 

36.2

%

Total sales revenue, net

$

637,737

 

 

$

474,737

 

 

$

163,000

 

 

34.3

%

 
 

 

Nine Months Ended November 30,

 

2020

 

2019

 

$ Change

 

% Change

Leadership Brand sales revenue, net (8)

$

1,288,614

 

 

$

1,012,346

 

 

$

276,268

 

 

27.3

%

All other sales revenue, net

300,810

 

 

252,721

 

 

48,089

 

 

19.0

%

Total sales revenue, net

$

1,589,424

 

 

$

1,265,067

 

 

$

324,357

 

 

25.6

%

Consolidated and Segment Net Sales from Core and Non-Core Business (3)

(Unaudited) (in thousands)

 

 

Three Months Ended November 30,

 

Housewares

 

Health & Home

 

Beauty

 

Total

Fiscal 2020 sales revenue, net

$

183,211

 

 

$

185,810

 

 

$

105,716

 

 

$

474,737

 

Core business

39,189

 

 

64,348

 

 

63,487

 

 

167,024

 

Non-Core business (Personal Care)

 

 

 

 

(4,024

)

 

(4,024

)

Change in sales revenue, net

39,189

 

 

64,348

 

 

59,463

 

 

163,000

 

Fiscal 2021 sales revenue, net

$

222,400

 

 

$

250,158

 

 

$

165,179

 

 

$

637,737

 

 

 

 

 

 

 

 

 

Total net sales revenue growth (decline)

21.4

%

 

34.6

%

 

56.2

%

 

34.3

%

Core business

21.4

%

 

34.6

%

 

60.1

%

 

35.2

%

Non-Core business (Personal Care)

%

 

%

 

(3.8

)%

 

(0.8

)%

 
 

 

Nine Months Ended November 30,

 

Housewares

 

Health & Home

 

Beauty

 

Total

Fiscal 2020 sales revenue, net

$

496,017

 

 

$

499,543

 

 

$

269,507

 

 

$

1,265,067

 

Core business

68,874

 

 

162,025

 

 

102,642

 

 

333,541

 

Non-Core business (Personal Care)

 

 

 

 

(9,184

)

 

(9,184

)

Change in sales revenue, net

68,874

 

 

162,025

 

 

93,458

 

 

324,357

 

Fiscal 2021 sales revenue, net

$

564,891

 

 

$

661,568

 

 

$

362,965

 

 

$

1,589,424

 

 

 

 

 

 

 

 

 

Total net sales revenue growth (decline)

13.9

%

 

32.4

%

 

34.7

%

 

25.6

%

Core business

13.9

%

 

32.4

%

 

38.1

%

 

26.4

%

Non-Core business (Personal Care)

%

 

%

 

(3.4

)%

 

(0.7

)%

SELECTED OTHER DATA

 

Reconciliation of Non-GAAP Financial Measures – GAAP Operating Income

to Adjusted Operating Income (Non-GAAP) (9)

(Unaudited) (in thousands)

 
 

 

Three Months Ended November 30, 2020

 

Housewares

 

Health & Home

 

Beauty

 

Total

Operating income, as reported (GAAP)

$

37,658

 

 

16.9

%

 

$

30,478

 

 

12.2

%

 

$

32,573

 

 

19.7

%

 

$

100,709

 

 

15.8

%

Restructuring charges

(12

)

 

%

 

 

 

%

 

 

 

%

 

(12

)

 

%

Subtotal

37,646

 

 

16.9

%

 

30,478

 

 

12.2

%

 

32,573

 

 

19.7

%

 

100,697

 

 

15.8

%

Amortization of intangible assets

523

 

 

0.2

%

 

2,454

 

 

1.0

%

 

1,524

 

 

1.0

%

 

4,501

 

 

0.7

%

Non-cash share-based compensation

2,712

 

 

1.2

%

 

2,359

 

 

0.9

%

 

1,668

 

 

1.0

%

 

6,739

 

 

1.1

%

Adjusted operating income (non-GAAP)

$

40,881

 

 

18.4

%

 

$

35,291

 

 

14.1

%

 

$

35,765

 

 

21.7

%

 

$

111,937

 

 

17.6

%

 

 

Three Months Ended November 30, 2019

 

Housewares

 

Health & Home

 

Beauty

 

Total

Operating income, as reported (GAAP)

$

42,272

 

 

23.1

%

 

$

24,372

 

 

13.1

%

 

$

12,625

 

 

11.9

%

 

$

79,269

 

 

16.7

%

Acquisition-related expenses (7)

 

 

%

 

 

 

%

 

1,475

 

 

1.4

%

 

1,475

 

 

0.3

%

Restructuring charges

 

 

%

 

 

 

%

 

12

 

 

%

 

12

 

 

%

Subtotal

42,272

 

 

23.1

%

 

24,372

 

 

13.1

%

 

14,112

 

 

13.3

%

 

80,756

 

 

17.0

%

Amortization of intangible assets

815

 

 

0.4

%

 

2,492

 

 

1.3

%

 

1,483

 

 

1.4

%

 

4,790

 

 

1.0

%

Non-cash share-based compensation

1,510

 

 

0.8

%

 

1,946

 

 

1.0

%

 

1,302

 

 

1.2

%

 

4,758

 

 

1.0

%

Adjusted operating income (non-GAAP)

$

44,597

 

 

24.3

%

 

$

28,810

 

 

15.5

%

 

$

16,897

 

 

16.0

%

 

$

90,304

 

 

19.0

%

 

 

Nine Months Ended November 30, 2020

 

Housewares

 

Health & Home

 

Beauty

 

Total

Operating income, as reported (GAAP)

$

106,294

 

 

18.8

%

 

$

95,782

 

 

14.5

%

 

$

54,887

 

 

15.1

%

 

$

256,963

 

 

16.2

%

Restructuring charges

251

 

 

%

 

 

 

%

 

104

 

 

%

 

355

 

 

%

Subtotal

106,545

 

 

18.9

%

 

95,782

 

 

14.5

%

 

54,991

 

 

15.2

%

 

257,318

 

 

16.2

%

Amortization of intangible assets

1,541

 

 

0.3

%

 

7,415

 

 

1.1

%

 

4,571

 

 

1.3

%

 

13,527

 

 

0.9

%

Non-cash share-based compensation

8,024

 

 

1.4

%

 

7,166

 

 

1.1

%

 

5,464

 

 

1.5

%

 

20,654

 

 

1.3

%

Adjusted operating income (non-GAAP)

$

116,110

 

 

20.6

%

 

$

110,363

 

 

16.7

%

 

$

65,026

 

 

17.9

%

 

$

291,499

 

 

18.3

%

 

 

Nine Months Ended November 30, 2019

 

Housewares

 

Health & Home

 

Beauty

 

Total

Operating income, as reported (GAAP)

$

109,170

 

 

22.0

%

 

$

51,836

 

 

10.4

%

 

$

19,990

 

 

7.4

%

 

$

180,996

 

 

14.3

%

Acquisition-related expenses (7)

 

 

%

 

 

 

%

 

1,475

 

 

0.5

%

 

1,475

 

 

0.1

%

Restructuring charges

90

 

 

%

 

 

 

%

 

971

 

 

0.4

%

 

1,061

 

 

0.1

%

Subtotal

109,260

 

 

22.0

%

 

51,836

 

 

10.4

%

 

22,436

 

 

8.3

%

 

183,532

 

 

14.5

%

Amortization of intangible assets

1,512

 

 

0.3

%

 

8,088

 

 

1.6

%

 

3,529

 

 

1.3

%

 

13,129

 

 

1.0

%

Non-cash share-based compensation

5,853

 

 

1.2

Helen of Troy Ltd

NASDAQ:HELE

HELE Rankings

HELE Latest News

HELE Stock Data

Audio and Video Equipment Manufacturing
Manufacturing
Link
Consumer Durables, Electronics/Appliances, Manufacturing, Audio and Video Equipment Manufacturing

About HELE

helen of troy limited (nasdaq: hele) has established a leadership position in the consumer products market through new product innovation, superior product quality and competitive pricing. helen of troy designs, produces, and markets brand-name personal care electrical products.